BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37115936)

  • 21. PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.
    Cheuk DK; Sabin ND; Hossain M; Wozniak A; Naik M; Rodriguez-Galindo C; Krasin MJ; Shulkin BL
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1097-106. PubMed ID: 22532252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selectively recommend
    Chen C; Xu T; Qiu X; Xie S; You Z; Hu Y; Zheng Y; Liang Z; Huang C; Chen T; Li L; Liu J; Fei Z
    Radiat Oncol; 2021 Nov; 16(1):229. PubMed ID: 34838075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
    King AD; Ma BB; Yau YY; Zee B; Leung SF; Wong JK; Kam MK; Ahuja AT; Chan AT
    Br J Radiol; 2008 Apr; 81(964):291-8. PubMed ID: 18344274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
    Xiao BB; Chen QY; Sun XS; Li JB; Luo DH; Sun R; Lin DF; Zhang X; Fan W; Lv XF; Han LJ; Wen YF; Yuan L; Guo SS; Liu LT; Liu SL; Tang QN; Liang YJ; Li XY; Lin C; Guo L; Mai HQ; Tang LQ
    Eur Radiol; 2021 Jul; 31(7):5222-5233. PubMed ID: 33416977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.
    Chang JT; Chan SC; Yen TC; Liao CT; Lin CY; Lin KJ; Chen IH; Wang HM; Chang YC; Chen TM; Kang CJ; Ng SH
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):501-7. PubMed ID: 15890593
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Qi S; Zhongyi Y; Yingjian Z; Chaosu H
    Sci Rep; 2017 Jan; 7():40552. PubMed ID: 28091565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [
    Dongxiang W; Liting L; Yujing L; Meijuan L; Shanshan G; Longbin X; Yanzhou C; Meiling C; Kang N; Haiqiang M; Linquan T; Qiuyan C
    Eur Radiol; 2023 Apr; 33(4):2840-2849. PubMed ID: 36422647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is unenhanced 18F-FDG-PET/CT better than enhanced CT in the detection of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma?
    Wu IS; Hung GU; Chang BL; Liu CK; Chang TH; Lee HS; Chen MK
    Ear Nose Throat J; 2016; 95(4-5):178-84. PubMed ID: 27140019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-body
    Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
    Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of 201TL SPECT/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma.
    Yen RF; Ting LL; Cheng MF; Wu YW; Tzen KY; Hong RL
    Head Neck; 2009 Jun; 31(6):717-24. PubMed ID: 19189341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
    Wang GH; Lau EW; Shakher R; Binns DS; Hogg A; Drummond E; Hicks RJ
    Ai Zheng; 2007 Jun; 26(6):638-42. PubMed ID: 17562272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary tumor volume measured by FDG PET and CT in nasopharyngeal carcinoma.
    Hung GU; Wu IS; Lee HS; You WC; Chen HC; Chen MK
    Clin Nucl Med; 2011 Jun; 36(6):447-51. PubMed ID: 21552022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of the post-radiotherapy
    Jeong Y; Jung IH; Kim JS; Chang SK; Lee SW
    Br J Radiol; 2019 Oct; 92(1102):20180045. PubMed ID: 30102562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodality radiomics analysis based on [
    Xu H; Lv W; Zhang H; Yuan Q; Wang Q; Wu Y; Lu L
    Eur Radiol; 2023 Oct; 33(10):6677-6688. PubMed ID: 37060444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDG PET/CT Demonstrated Unilateral Striatum Hypometabolism in a Case of Advanced Nasopharyngeal Cancer.
    Lu XP; Chen AC; Wu MC; Tseng HC; Kao PF
    Clin Nucl Med; 2024 Jan; 49(1):104-105. PubMed ID: 37976532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging.
    Chan SC; Ng SH; Chang JT; Lin CY; Chen YC; Chang YC; Hsu CL; Wang HM; Liao CT; Yen TC
    Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1032-40. PubMed ID: 16622711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDG PET/CT in the management of nasopharyngeal carcinoma.
    Mohandas A; Marcus C; Kang H; Truong MT; Subramaniam RM
    AJR Am J Roentgenol; 2014 Aug; 203(2):W146-57. PubMed ID: 25055290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The valuable role of dynamic
    Huang X; Zhuang M; Yang S; Wang Y; Liu Q; Xu X; Xiao M; Peng Y; Jiang P; Xu W; Guo S; Wang R; Wei W; Zhong G; Zhou Y; Peng S; Li X; Cui J; Wang S; Zhang Y; Liu Z
    Radiother Oncol; 2023 Feb; 179():109440. PubMed ID: 36566989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
    Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
    Wei J; Pei S; Zhu X
    Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.